They also show that SCF–c-kit axis is a key regulator for lung cancer stem cell (CSC) survival and proliferation in addition to self-renewal property and provide evidence that blocking stem cell factor (SCF)–c-kit signaling is sufficient to inhibit CSC proliferation and survival promoted by chemotherapy. The gene discussed is KIT; the disease is lung carcinoma.